We serve Chemical Name:2-Chloro-5-{[(3,4,5-triethoxybenzoyl)carbamothioyl]amino}benzoic acid CAS:1017060-05-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![2-Chloro-5-{[(3,4,5-triethoxybenzoyl)carbamothioyl]amino}benzoic acid](https://a.dearchem.com/CAS2/1017060-05-7.png)
Chemical Name:2-Chloro-5-{[(3,4,5-triethoxybenzoyl)carbamothioyl]amino}benzoic acid
CAS.NO:1017060-05-7
Synonyms:4-(1,1-dimethylethyl)-3-(methoxy)benzaldehyde;Benzaldehyde,4-[(1,1-dimethyl-2-propenyl)oxy];4-(1,1-dimethylallyloxy)benzaldehyde
Molecular Formula:C21H23ClN2O6S
Molecular Weight:466.93500
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:148.74000
Exact Mass:466.09700
LogP:5.15640
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-(1,1-dimethylethyl)-3-(methoxy)benzaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-(1,1-dimethylallyloxy)benzaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzaldehyde,4-[(1,1-dimethyl-2-propenyl)oxy] Use and application,4-(1,1-dimethylallyloxy)benzaldehyde technical grade,usp/ep/jp grade.
Related News: Over the duration of this study, investigators observed a 4.2% reduction in annualised absolute risk of cardiovascular death or heart failure hospitalisations compared to placebo. tert-butyl ((2S,3R)-1-(3-(benzyloxy)-5-fluorophenyl)-3-hydroxy-4-((1-(3-isopropylphenyl)cyclohexyl)amino)butan-2-yl)carbamate manufacturers Systemic lupus erythematosus is an autoimmune disease in which the immune system attacks healthy tissue in the body. It is a chronic and complex disease with a variety of clinical manifestations that can impact many organs and can cause a range of symptoms including pain, rashes, fatigue, swelling in joints and fevers. ethyl 4-(3-(3,4-dichlorobenzoyl)thioureido)benzoate suppliers Though the program obtained priority review from FDA back in November, analysts expressed skepticism in July 2020 after it failed to prove superior to the companies’ other drug Lumizyme in improving respiratory function in a Phase III trial. tetrakis[[methyl(methylcarbamoyl)amino]methyl]phosphanium vendor & factory.
